Loading stock data…
Avantor, Inc. (AVTR)
$15.25+0.28 (+1.87%)
Market ClosedLast close Sep 8
Avantor, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Avantor, Inc. in the Healthcare sector is trading at $15.25 with a market capitalization of $9.2B. Wall Street consensus targets $14.56 (14 analysts), implying a -4.5% move over the next 12 months. The stock is currently near its 52-week high of $15.93, remaining 46.8% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.69B↑ | $1.58B↓ | $1.66B↑ | $1.62B↓ | $1.68B |
| Gross Profit | $537.00M↑ | $500.70M↓ | $523.90M↓ | $526.50M↓ | $554.10M |
| Operating Income | $121.80M↑ | $99.50M↓ | $131.50M↓ | $136.20M↑ | $128.80M |
| Net Income | $38.10M↓ | $43.30M↓ | $52.40M↑ | -$711.80M↓ | $64.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle Ea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.89
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-10.27%
Volume
Today's trading volume
12.50M
Recent News
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition
In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades of global manufacturing and supply chain experience from SkinHealth Systems, Avantor, Medtronic, and Honeywell, while long-time operations leader Mr. Peterson shifted to a Senior Advisor role through March 2027 to support continuity. This leadership transition highlights Merit's focus on strengthening global operations and supply chain...
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.